Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26767096

Outcomes of Extended-Infusion Piperacillin-Tazobactam: A Retrospective Analysis of Critically Ill Patients

Author
LEE, Grace C1 2 3 ; LIOU, Hansheng4 ; YEE, Russell5 ; QUAN, Clifford F6 ; NELDNER, Katherine7
[1] Department of Medicine, School of Medicine, Pharmacotherapy Education and Research Center, University of Texas Health Science Center San Antonio, San Antonio, Texas, United States
[2] Division of Pharmacotherapy, University of Texas at Austin College of Pharmacy, Austin, Texas, United States
[3] Department of Pharmacy, Kaiser Permanente Antioch Medical Center, Antioch, California, United States
[4] Department of Pharmacy, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, California, United States
[5] Department of Pharmacy, Presbyterian Intercommunity Hospital, Whittier, California, United States
[6] Department of Infectious Diseases, Kaiser Permanente Antioch Medical Center, Antioch, California, United States
[7] Department of Infectious Diseases, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, California, United States
Source

Clinical therapeutics. 2012, Vol 34, Num 12, pp 2297-2300, 4 p ; ref : 10 ref

ISSN
0149-2918
Scientific domain
Pharmacology drugs
Publisher
Elsevier, Bridgewater, NJ
Publication country
United States
Document type
Article
Language
English
Author keyword
dosing pharmacodynamics piperacillin tazobactam
Keyword (fr)
Activité biologique Antibactérien Antibiotique Etude longitudinale Homme Infusion Malade état grave Perfusion Pipéracilline Posologie Pronostic Tazobactam Pharmacodynamie Dérivé de la pénicilline Enzyme Hydrolases Inhibiteur enzyme β-Lactamase β-Lactamines
Keyword (en)
Biological activity Antibacterial agent Antibiotic Follow up study Human Infusion Critically ill Perfusion Piperacillin Posology Prognosis Tazobactam Pharmacodynamics Penicillin derivatives Enzyme Hydrolases Enzyme inhibitor β-Lactamase β-Lactams
Keyword (es)
Actividad biológica Antibacteriano Antibiótico Estudio longitudinal Hombre Infusión Enfermo estado grave Perfusión Piperacilina Posología Pronóstico Tazobactam Farmacodinámica Penicilinas Enzima Hydrolases Inhibidor enzima β-Lactamase β-Lactams
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments

Discipline
General pharmacology
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
26767096

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web